Table 3.
Correlations the clinical characteristics among CCL19 and non-cirrhotic HCC in TCGA
| Variables | N | Non-cirrhotic HCC | |
|---|---|---|---|
| CCL19 | |||
| Low/high expression case (n) | p value | ||
| Gender | |||
| Male | 82 | 64/18 | 0.585 |
| Female | 50 | 41/9 | |
| Age at diagnosis | |||
| ≥ 60 | 80 | 68/12 | 0.054 |
| < 60 | 52 | 37/15 | |
| T stage | |||
| T1/T2 | 97 | 76/21 | 0.846 |
| T3/T4 | 33 | 27/6 | |
| TX | 1 | 1/0 | |
| NA | 1 | 1/0 | |
| N stage | |||
| N0 | 91 | 73/18 | 0.853 |
| N1 | 1 | 1/0 | |
| NX | 40 | 31/9 | |
| M stage | |||
| M0 | 90 | 74/16 | 0.178 |
| M1 | 4 | 2/2 | |
| MX | 38 | 29/9 | |
| Pathologic stage | |||
| I/II | 91 | 72/19 | 0.741 |
| III/IV | 33 | 27/6 | |
| NA | 8 | 6/2 | |
| Vascular invasion | |||
| None | 87 | 69/18 | 1.000 |
| Micro | 33 | 26/7 | |
| Macro | 6 | 5/1 | |
| NA | 6 | 5/1 | |
| HBV infection | |||
| Yes | 38 | 27/11 | 0.176 |
| No | 88 | 72/16 | |
| NA | 6 | 6/0 | |
| HCV infection | |||
| Yes | 14 | 7/7 | 0.016 |
| No | 112 | 92/20 | |
| NA | 6 | 6/0 | |
NA not applicable
The significant p value is marked with italic type